---
title: "Zhongheng Group: Net profit of 27.0776 million yuan in the first half of 2025, a year-on-year increase of 23.59%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255235871.md"
description: "Zhongheng Group announced that in the first half of 2025, operating revenue was 1.451 billion yuan, a year-on-year increase of 2.84%. Net profit was 27.0776 million yuan, a year-on-year increase of 23.59%"
datetime: "2025-08-29T14:12:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255235871.md)
  - [en](https://longbridge.com/en/news/255235871.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255235871.md)
---

# Zhongheng Group: Net profit of 27.0776 million yuan in the first half of 2025, a year-on-year increase of 23.59%

Zhongheng Group announced that in the first half of 2025, operating revenue was 1.451 billion yuan, a year-on-year increase of 2.84%. Net profit was 27.0776 million yuan, a year-on-year increase of 23.59%

### Related Stocks

- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [Exploring Three Undiscovered Gems in the Middle East Market](https://longbridge.com/en/news/286881831.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [China Telecom's Shares Rise After Becoming Last of Country's Big Three Telcos to Roll Out Token Plans](https://longbridge.com/en/news/286859736.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [Hamlet BioPharma announces investor meeting alongside Q3 report release](https://longbridge.com/en/news/287189797.md)